- Research article
- Open Access
Potentially inappropriate medications used by the elderly: prevalence and risk factors in Brazilian care homes
BMC Geriatrics volume 13, Article number: 52 (2013)
The use of potentially inappropriate medications (PIM) among the elderly is a serious public health problem because it is intrinsically linked to increased morbidity and mortality, causing high costs to public health systems. This study’s objective was to verify the prevalence of and the factors associated with the use of PIMs by elderly Brazilians in institutional settings.
We performed a transversal study, by consulting the case files of elderly people living in Long Term Care for the Elderly (LTC) in towns in the State of São Paulo, Brazil, as well as structured interviews with the nurses responsible for them.
We identified PIMs using the list of recently updated Beers criteria developed by a group of specialists from the American Geriatrics Society (AGS), who reviewed the criteria based on studies with high scientific evidence levels. We defined the factors studied to evaluate the association with PIM use prior to the statistical analyses, which were the chi-square test and multiple logistic regression.
Among the elderly who used drugs daily, 82.6% were taking at least one PIM, with antipsychotics (26.5%) and analgesics (15.1%) being the most commonly used. Out of all the medications used, 32.4% were PIMs, with 29.7% of these being PIMs that the elderly should avoid independent of their condition, 1.1% being inappropriate medication for older adults with certain illnesses or syndromes, and 1.6% being medications that older adults should use with caution. In the multivariate analysis, the factors associated with PIM use were: polypharmacy (p = 0.0187), cerebrovascular disease (p = 0.0036), psychiatric disorders (p < 0.0001) and dependency (p = 0.0404).
The results of this study showed a high prevalence of PIM use in institutionalized elderly Brazilian patients. and the associated factors were polypharmacy, psychiatric disorders, cerebrovascular diseases and dependency.
The elderly’s use of inappropriate medications is a serious public health problem because it is intimately related to adverse drug reactions [1, 2], and these, in turn, lead to an exceptional increase in indices of morbidity and mortality, generating wasted health resources , especially among the very old .
The use of potentially inappropriate medications (PIMs) has been studied in different health care scenarios, and despite the wide range of information on the subject, health professionals continue to prescribe many PIMs to the elderly. The use of PIMs among residents of long-term care for the elderly (LTC)—which, according to Morais , consist of groups of elderly people with particularly high uses of medications differs according to the countries where the studies have been performed. In Japan, Niwata et al.  found a PIM use rate of 21.1% in LTC, which included not only nursing homes, but also other institutions, such as hospitals and elderly care centers. In Malaysia, the PIM use rate among the elderly residents in an LTC was 32.7% .
In a review of studies performed in LTCs in Europe and the United States, Gallagher et al.  found a prevalence of 40%.
After an extensive review of the existing literature, we found only one study performed in a Brazilian LTC by Castellar et al. , who found a PIM use prevalence of 46.2%.
Holistic therapeutic care, including pharmaceutical care, is an area of interest for the Brazilian Public Health System (Sistema Único de Saúde [SUS]), which plays an essential role in guaranteeing access to medication for the whole population . However, according to Gomes and Caldas , medical professionals in Brazil lack knowledge about prescribing PIMs to the elderly. In addition, the fact that the SUS does not have the most adequate medications for the elderly regularly available increases the risk of inappropriate medications being given to this group.
The Beers Criteria are used to classify and describe the risks related to these medications [11–13]. For 20 years, the Beers Criteria list has been the most widely consulted list for evaluating the prescription of medication to the elderly [14, 15].
However, these criteria must be updated regularly to reflect newly launched medications and the publication of new evidence related to the use of these medications. As a result, a multidisciplinary panel of specialists (American Geriatrics Society [AGS]) after a rigorous systematic review, recently updated and expanded the criteria .
The medications included in the new list are subdivided into three main categories: 34 medications that are potentially inappropriate because they have a high risk of adverse reactions or are of limited effectiveness in the elderly; 14 medications that are potentially inappropriate for elderly people with certain pathologies and/or syndromes since they can exacerbate the pre-existing disease/syndrome; 14 medications that should be used with caution by the elderly. These medications can be associated with greater risk than benefit in the elderly . In light of this situation, the main objectives of this study were to verify the prevalence of prescribing inappropriate medications to the elderly by using the updated Beers Criteria and to determine what factors are associated with inappropriate prescriptions in elderly institutionalized Brazilians.
We performed a transversal study by consulting the files of elderly residents of care homes, with an age of ≥60 years and through structured interviews with the nurses responsible for the elderly residents in these institutions during the period from December 2011 to May 2012.
We applied an age limit of 60 years for the sample participants. This age limit is justified because in developing countries, such as Brazil, the World Health Organization (WHO)  considers people to be elderly when they are 60 years or older. This threshold differs from that in developed countries, where the age limit is 65 years or above. Moreover, in Brazil, certain legal measures describe the elderly population based on this age range [18, 19].
We performed data collection in four towns in the state of São Paulo, Brazil. Three of these towns were large (population between 100,000 and 900,000 inhabitants) and one was medium sized (population between 50,001 and 100,000 inhabitants) . The selection of towns was by convenience. To obtain a more homogenous sample, the study population included all of the elderly people living in all six of the LTCs in these four towns.
We excluded people who had not yet reached 60 years of age during the data collection period, those who did not fully reside at the institution, and those who died during this period.
The six institutions housed elderly people with the same socio-economic characteristics. The majority of the population was illiterate, had a low educational level, and had retired on a low income.
Data was obtained by documentary analysis of the medical records of the elderly residents, complemented by interviews with the nurses responsible for each LTC. For the interviews, we used a previously tested structured questionnaire with open and closed questions, and we recorded the following data: social characteristics (age, household income, educational level) and questions related to health, such as hospital admissions during the year, pathologies, symptoms or syndromes present, as well as a diary of the medications prescribed (name of medication, indication for medication, and symptoms after taking the medication). We also recorded data that evaluated the dependency level, using the Katz Index , which was applied to all the medical records.
During the month prior to data collection, all the medical drugs prescribed were collected, during which all standard information contained in the records was registered and the daily prescription charts or prescriptions for each resident reviewed, complemented when necessary by information from the packaging and leaflets provided. All industrial medical drugs and master formulas were included in the database and analyzed, except for those whose composition could not be clearly determined (homeopathics, phytotherapies and teas). The medications were classified into therapeutic categories, according to their principle active agent(s), using the Anatomical-Therapeutic-Chemical Classification System (ATC) as a reference .
Medications that had more than one principle active agent were placed in the therapeutic category of the main principle agent; products with different pharmacological actions were classified taking into consideration the condition for which they were prescribed or used, as described by Coelho Filho, Marcopito, and Castelo .
This study was performed in compliance with the Helsinki Declaration and was approved by the Research Ethics Committee of UNESP- the State University of São Paulo (Universidade Estadual Paulista).
The dependent variable was the use of at least one inappropriate medication by the elderly, defined as the daily use of medications that have been described by the recently updated Beers criteria .
With updates to the Beers Criteria, certain medications from the previous list were excluded  because no studies based on plausible evidence showed them to be potential causes of adverse reactions in the elderly. On the other hand, other drugs were included and presented as inappropriate medications for use in the elderly, based on the evidence of new studies or because they were recently launched in the market.
Thus, medications inappropriate for the elderly found by the study were classified as “medications the elderly should avoid, independent of their diseases and conditions”, “medications inappropriate for the elderly with certain diseases or syndromes”, and “medications that should be used with caution”, as proposed by the AGS .
To classify medications as “medications inappropriate for the elderly with certain diseases or syndromes”, we examined the records of each senior citizen and the conditions found, duly identified according to the International Classification of Diseases, Version 10 (ICD-10) .
We should emphasize that not all of the medications on the Beers list are available in Brazil. Therefore, we evaluated and classified only those medications sold in the country, which were used by the institutionalized elderly participants and included in the updated list.
Sociodemographic variables and the variables related to health obtained were categorized for the purposes of statistical analysis. Age was categorized as: ≥ 75 and < 75 and hospital admissions as: yes/no, depending on whether the person had or had not been hospitalized during the year prior to the research;
We identified polymorbidity when a patient had four or more diseases , and categorized it as follows: no (0–3 diseases) and yes (≥4 diseases).
We measured the dependency level of the elderly using the scale designed by Katz et al.  as follows: “dependent” (elderly classified as “dependent” or “partially dependent” by the scale) and “non-dependent” (elderly classified as “independent” by the scale).
An elderly person with a diagnosis of schizophrenia, oligophrenia, or Alzheimer’s disease was considered to have a psychiatric disorder. Cerebrovascular diseases included: epilepsy, CVA sequlae, paraplegia, and atrophy of the limbs.
Elderly people were classified as having depression when the institution’s medical team had made this diagnosis and when they were receiving treatment for this pathology.
Univariate analyses were performed to describe the categorical variables and factors associated with the use of medications inappropriate for the elderly. P-values were generated using the Chi-square association test and Fisher’s exact test.
Next, we performed a multivariate logistic regression model, including in the model any variables with values lower than or equal to 20% in the univariate analysis, which were dependency, polypharmacy, polymorbidity, depression, cerebrovascular disease, psychiatric disorders, and diabetes mellitus.
Through this analysis, we obtained the values for the odds ratio (OR), and the significance level adopted was 5%.
All analyses were conducted using Biostat statistical software (version 5.3; Mamirauá Institute for Sustainable Development) .
Out of a total of 268 elderly identified, 3 did not fully reside at the institution (they were there only during the day and returned to their homes at night), and 4 would not yet be 60 years of age within the study period; the remaining 261 were enrolled as participants. Additional file 1: Table S1 shows the characteristics of the participants in this study. Of these, (96.9%) used medication continuously, with an average of 5.7 medications used per day.
The 1452 medications prescribed to this study’s elderly involved 215 different active principles, the majority of which (35.3%) affected the central nervous system (CNS). Figure 1 shows the medications the participants used most, classified into their pharmacological/therapeutic subgroups.
In terms of the inappropriate use of medication, 82.6% of the elderly who used medication on a daily basis received a minimum of one medication that was a PIM, with antipsychotics (26.5%) and analgesics (15.1%) being the most frequently used therapeutic categories (Additional file 2: Table S2).
Anxiolytics (12.5%), antiarrythmics (7.2%), and antidepressants (6.8%) were found in more than 30 prescriptions (Additional file 2: Table S2).
Out of all the medications prescribed and used, 32.4% were PIMs for the elderly. This percentage was divided into the three categories proposed by the AGS as follows: 29.7% PIMs for use by the elderly, independent of any diagnosis; 1.1% medications that were counter-indicated for the elderly with certain pathologies or syndromes; and 1.6% medications that should be used with caution by the elderly (Additional file 2: Table S2).
To analyze associations, we considered the use of at least one medication inappropriate for the elderly. Our univariate analysis revealed a significant association between PIM use and polypharmacy (p ≤ 0.0001), polymorbidity (p ≤ 0.0001), psychiatric disorders (p ≤ 0.0001), depression (p = 0.0204), cerebrovascular disease (p = 0.0048), diabetes mellitus (p = 0.0108) and dependency (p=0.1737) (Additional file 3: Table S3).
Applying multivariate analysis, we observed that the variables of polypharmacy (p = 0.0187), psychiatric disorders (p ≤ 0.0001), cerebrovascular disease (p = 0.0036) and dependency (p=0.0404) were associated significantly with reports of PIM use. However, the variables of polymorbidity, depression and diabetes mellitus lost their significance at this stage of analysis, as the data in Additional file 3: Table S3 shows.
The main results of this study demonstrate a high prevalence for PIM use among elderly Brazilians in institutions, with a predominance of antipsychotics among the therapeutic classes of medications used. We found an association with polypharmacy, a factor consistently reported in the literature. However, certain specific conditions such as psychiatric disorders, dependency, and cerebrovascular diseases were associated factors that we identified for the first time.
Use of medications
The average consumption of medications used daily by the present study, although it may look high, is actually lower than that of other studies [30–33]. However, in terms of the prevalence of medicines identified as inappropriate, the result observed was potentially high (82.6%).
In terms of the most commonly used therapeutic classes, we observed a predominance of medications acting on the central nervous system (35.3%), with antipsychotics (26.5%) and analgesics (15.1%) being the PIMs most frequently used. These findings corroborate the results of Mann et al.  and Fortselund et al. . The predominant use of antipsychotics among the residents of LTCs reflects the high number of older adults affected by mental or behavioral disorders, as reported by Converso and Iartelli  and Lenardt et al. . It is to be expected that these disorders are among the main pathologies of residents of LTCs because these elderly people require more care and more time dedicated to them. Therefore, family members end up placing them in LTCs.
Factors associated with PIM use
We observed a clear association between PIM use and polypharmacy, but not with age, sex, or hospital admissions. Wahruch et al.  and Ruggiero et al.  reported the same findings. Moreover, numerous studies in the literature [1, 32, 38–41] have demonstrated a significant relationship between polypharmacy and PIM use. As Bao et al.  noted, it is not surprising that polypharmacy is a factor strongly associated with PIM use since patients taking many medications have a better chance of receiving an inappropriate prescription and are more likely to have multiple pathologies, hospitalizations, and consultations with multiple doctors of various specialties, which could lead to prescriptions of PIMs.
Elderly people with cerebrovascular disease and psychiatric disorders have 7.3 and 5.3 times higher chances of using PIMs, respectively, than those unaffected by these illnesses.
According to Wawruch et al. , the association between PIM use and certain pathologies could be an important marker of incorrect disease management and a tendency for irrational prescriptions. This finding shows the importance of understanding what conditions or factors are associated with using inappropriate medication, as having this knowledge makes it possible to evaluate the quality of the health care provided.
Another factor associated with PIM use, according to this study’s results, was dependency. Dependent elderly people do not practice activities, not simply physical activities, but also basic and routine activities, which can affect their quality of life; this fact may explain this association.
As a result, this situation can lead to pathologies, such as circulatory disturbances. In addition to these diseases, we verified that polymorbidity occurs in these cases, which in turn leads to a greater consumption of medication and increases the likelihood of receiving an inappropriate prescription, as noted above.
Strengths of the study and implications for the Brazilian health system
The results of this study are relevant, above all, because there is a dearth of knowledge about pharmacotherapy for elderly Brazilians living in institutions. In addition to addressing a theme about which little is known in Brazil, this study is the first to examine the factors that might influence PIM use in Brazilian LTCs.
We also want to emphasize that this study is one of the first studies to evaluate the use of medications inappropriate for the elderly using the revised Beers criteria , and to identify new risk factors for the use of PIMs.
The Beers Criteria list is an indispensible tool to verify the use of inappropriate medications by the elderly and to prevent side effects caused by using inappropriate medications. As a consequence, the use of this tool would reduce the expense of public funds used to finance the health care service (SUS).
Moreover, the results of this study indicate the need to train health professionals responsible for caring for elderly Brazilians living in institutions, given the high prevalence of PIM use.
This result may offer a possible explanation for why Brazilian hospitals and emergency institutions are so overcrowded, given that the PIMs used by 82.6% of the elderly in this study have more risks than benefits and are associated with serious side effects, which are responsible for 10 to 20% of acute hospital admissions .
In addition, these results can help administrators and health professionals at these institutions to evaluate their health services, especially pharmacotherapy. Based on these data, it is possible to plan measures to improve medical prescribing in LTCs.
Limitations of the study
One of the limitations of this study is the fact that the results cannot be generalized to other countries. Moreover, the results are not representative of the elderly living in LTCs in other parts of Brazil, especially the poorest regions. Thus, it is fundamental that additional studies be performed to determine not only the prevalence of inappropriate prescribing, but also its impact on morbimortality within the elderly, especially those in institutions.
Another limitation of this study arises from the fact that the updated Beers list was only recently published. As a result, health professionals may not have had sufficient time to adapt to new scientific evidence. Thus, we need to perform further studies with the same methodological design to verify whether there have been improvements in prescribing appropriate medications to the elderly.
Moreover, we suggest that there should be studies that adapt the updated Beers Criteria to medication available in Brazil. Using the previous Beers-Fick  Criteria list, Gorzoni et al.  verified that the criteria did not cover all situations involving PIM use in elderly Brazilians. These criteria do not include drugs in common use in Brazil, such as antitussives, cinnarizine, diltiazem, piracetam, quinolones, xanthines, creams, pomades, and eyewashes that should be prescribed with caution to the elderly. As an example, we cite the pharmacological action of certain eyewashes, which may lead to cardiovascular changes and psychiatric disorders in elderly patients [43, 44]. Thus, the prevalence of PIM use in this study, although extremely high, may still be underreported.
This study’s results indicated that there is a high prevalence of PIM use among elderly Brazilians living in institutions, with medications acting on the CNS being the most common group of drugs in use, a circumstance which fits with the high percentage of elderly people who have mental health problems.
We also observed that polypharmacy was a main factor associated with PIM use in residents of institutions, a finding which reflects the multiple pathologies present, and the prevalence of psychiatric disorders, cerebrovascular disease, and dependency.
Chen LL, Tangiisuran B, Shafie AA, Hassali MA: Evaluation of potentially inappropriate medications among older residents of Malaysian nursing homes. Int J Clin Pharm. 2012, 34: 596-603. 10.1007/s11096-012-9651-1.
Aparasu RR, Mort JR: Inappropriate prescribing for the elderly: beers criteria-based review. Ann Pharmacother. 2000, 34: 338-346.
Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT: Appropriate prescribing in elderly people: how well can it be measured and optimised?. Lancet. 2007, 370: 173-184. 10.1016/S0140-6736(07)61091-5.
Klarin I, Wimo A, Fastbom J: The association of inappropriate drug use with hospitalisation and mortality: a population based study of the very old. Drugs Aging. 2005, 22: 69-82. 10.2165/00002512-200522010-00005.
Morais CPM: Evaluation of the consumption of medications in a nursing institution. 1998, Federal University of Rio de Janeiro: Dissertation
Niwata S, Yamada Y, Ikegami N: Prevalence of inappropriate medication using beers criteria in Japanese long-term care facilities. BMC Geriatr. 2006, 11: 6-
Gallagher P, Barry P, O'Mahony D: Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007, 32: 113-21. 10.1111/j.1365-2710.2007.00793.x.
Castellar JI, Karnikowski MGO, Vianna LG, Nóbrega OT: A study of pharmacotherapy prescribed to the elderly in a long-stay institution in brazil. Acta Med Port. 2007, 20: 97-105.
Brazil: National Health Council: Resolution CNS 338/2004. http://portal.saude.gov.br/portal/arquivos/pdf/resol_cns338.pdf,
Gomes HO, Caldas CP: Inappropriate use of medication by the elderly: polypharmacy and its effects. Rev HUPE. 2008, 7: 88-99.
Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC: Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA division of geriatric medicine. Arch Intern Med. 1991, 151: 1825-1832. 10.1001/archinte.1991.00400090107019.
Beers MH: Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med. 1997, 157: 1531-1536. 10.1001/archinte.1997.00440350031003.
Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH: Updating the beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003, 163: 2716-2724. 10.1001/archinte.163.22.2716.
Gorzoni ML, Fabri RMA, Pires SL: The beers-fick criteria and generic medications in brazil. Rev Assoc Med Bras. 2008, 54: 353-356.
Resnick B, Pacala JT: 2012 Beers criteria. J Am Geriatr Soc. 2012, 60: 612-61. 10.1111/j.1532-5415.2012.03921.x.
Society AG: Beers criteria update expert panel: American geriatrics society updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012, 2012 (60): 616-631.
World Health Organization: The uses of epidemiology in the study of the elderly. 1984, Brazil: Law n. 8842/94: WHO, Establishes a National Policy for the Elderly. http://www.planalto.gov.br/ccivil_03/leis/l8842.htm
Brasil: Lei n. 8842/94: Estabelece a política nacional do idoso. http://www.planalto.gov.br/ccivil_03/leis/l8842.htm,
Brazil: Law n. 57/2003: Discusses the statute for the elderly and offers additional measures. http://www.crde-unati.uerj.br/pdf/estatuto.pdf,
Brazilian Institute of Statistical Geography (Instituto Brasileiro de Geografia e Estatística – IBGE: Demographic census. 2010, ftp://ftp.ibge.gov.br/Censos/Censo_Demografico_2010/Entorno_dos_Domicilios/entorno.pdf
Katz S, Downs TD, Cash HR, Grotz RC: Progress in development of the index of ADL. Gerontologist. 1970, 10: 20-30. 10.1093/geront/10.1_Part_1.20.
Anatomical Therapeutic Chemical: Classification. Index with defined daily doses (DDDs). http://www.whocc.no/atc_ddd_index,
Coelho Filho JM, Marcopito LF, Castelo A: Profile for medication use by the elderly in an urban area of the northeast of brazil. Rev Saúde Pública. 2004, 38: 557-564.
World Health Organization: International statistical classification of diseases and related health problems. http://apps.who.int/classifications/icd10/browse/2010/en,
Wawruch M, Fialova D, Zikavska M, Wsolova L, Jezova D, Kuzelova M, Liskova S, Krajcik S: Factors influencing the use of potentially inappropriate medication in older patients in Slovakia. J Clin Pharm Ther. 2008, 33: 381-392. 10.1111/j.1365-2710.2008.00929.x.
Hanlon JT, Schmader KE, Ruby CM, Weinberger M: Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc. 2001, 49: 200-209. 10.1046/j.1532-5415.2001.49042.x.
Klarin I, Fastbom J, Wimo A: A population-based study of drug use in the very old living in a rural district of Sweden, with focus on cardiovascular drug consumption: comparison with an urban cohort. Pharmacoepidemiol Drug Saf. 2003, 12: 669-678. 10.1002/pds.878.
Pizzol TSD, Pons ES, Hugo FN, Bozzetti MC, Sousa MLR, Hilgert JB: Use of medication by elderly residents in urban and rural areas of a town in the south of brazil: a population-based study. Cad Saúde Pública. 2012, 28: 104-114.
Ayres M, Ayres M, Ayres DL, Santos AAS: BioEstat: statistical applications in the area of biomedical sciences. 2007, Belém: MCT/CNPq
Oliveira Martins S, Soares MA, Foppe van Mil JW, Cabrita J: Inappropriate drug use by Portuguese elderly outpatients: effect of the beers criteria update. Pharm World Sci. 2006, 28: 296-301. 10.1007/s11096-006-9046-2.
Rajska-Neumann A, Wieczorowska-Tobis K: Polypharmacy and potential inappropriateness of pharmaco-logical treatment among community-dwelling elderly patients. Arch Gerontol Geriatr. 2007, 44: 303-309.
Hosia-Randell HM, Muurinen SM, Pitkälä KH: Exposure to potentially inappropriate drugs and drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study. Drugs Aging. 2008, 25: 683-692. 10.2165/00002512-200825080-00005.
Nixdorff N, Hustey FM, Brady AK, Vaji K, Leonard M, Messinger-Rapport BJ: Potentially inappropriate medication and adverse drug effects in elders in the ED. Am J Emerg Med. 2008, 26: 697-700. 10.1016/j.ajem.2007.12.007.
Mann E, Kopke S, Haastert B, Pitkälä K, Meyes G: Psychotropic medication use among nursing home residents in Austria: a cross-sectional study. BMC Geriatr. 2009, 9: 18-10.1186/1471-2318-9-18.
Fortselund L, Eike MC, Gjerberg E, Vist GE: Effect of interventions to reduce potentially inappropriate use of drugs in nursing homes: a systematic review of randomized controlled trials. BMC Geriatr. 2011, 11: 16-10.1186/1471-2318-11-16.
Converso MER, Iartelli I: Character and analysis of the mental and functional state of elderly people institutionalized in long-stay public institutions. J Bras Psiquiatr. 2007, 56: 267-272. 10.1590/S0047-20852007000400005.
Lenardt MH, Michel T, Wachholz PA, Borghi AS, Seima MD: The performance of institutionalized elderly people on the mental state miniexam. Acta Paul Enferm. 2009, 22: 638-44. 10.1590/S0103-21002009000500007.
Ruggiero C, Dell`Aquila G, Gasperini B, Onder G, Lattanzio F, Volpato S, Corsonello A, Maraldi C, Bernabei R, Cherubini A: Potentially inappropriate drug prescriptions and risk of hospitalization among older, Italian nursing home residents: the ULISSE project. Drugs Aging. 2010, 27: 747-758. 10.2165/11538240-000000000-00000.
Akazawa M, Imai H, Igarashi A, Tsutani K: Potentially inappropriate medication use in a elderly Japanese patients. Am J Geriatr Pharmacother. 2010, 8: 146-160. 10.1016/j.amjopharm.2010.03.005.
Varallo FR, Capucho HC, Planeta CS, Mastroianni PC: Safety assessment of potentially inappropriate medications (PIM) use in older people and the factors associated with hospital admission. J Pharm Pharm Sci. 2011, 14: 283-290.
Bao Y, Shao H, Bishop T, Schackman BR, Bruce ML: Inappropriate medication in a national sample of US elderly patients, receiving home health care. J Gen Intern Med. 2012, 27: 304-310. 10.1007/s11606-011-1905-4.
Teixeira JJV, Lefèvre F: Medical prescriptions with an eye to elderly patients. Rev Saúde Pública. 2001, 35: 207-13.
Shiuey Y, Eisenberg MJ: Cardiovascular effects of commonly used ophthalmic medications. Clin Cardiol. 1996, 19: 5-8. 10.1002/clc.4960190104.
Diamond JP: Systemic adverse effects of topical ophthalmic agents. Implications for older patients. Drugs Aging. 1997, 11: 352-60. 10.2165/00002512-199711050-00003.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2318/13/52/prepub
The authors thank FAPESP – (the Foundation for Research Support of the State of São Paulo, Fundação de Amparo à Pesquisa do Estado de São Paulo) for their financial support (case number 2011/12525-5) and CAPES (the Agency for the Evaluation and Support of Graduate Research, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior) for providing assistance for Thaís Jaqueline Vieira de Lima’s doctoral studies.
The authors declare that they have no conflicts of interests.
TJVL and CASG were responsible for study concept and design, writing and reviewing of the manuscript. AJIG and DHS carried acquisition of data, data analysis and interpretation, OS performed statistical analysis and critical review of manuscript. All authors read and approved the final manuscript.
Electronic supplementary material
About this article
Cite this article
Vieira de Lima, T.J., Garbin, C.A.S., Garbin, A.J.Í. et al. Potentially inappropriate medications used by the elderly: prevalence and risk factors in Brazilian care homes. BMC Geriatr 13, 52 (2013). https://doi.org/10.1186/1471-2318-13-52
- Drug utilization
- Inappropriate prescribing